Skip to main content

Evidence review

Peptide Detail

Library/Hexarelin
well researchedCautionResearch Only

Hexarelin

Examorelin / HEX / Growth Hormone Releasing Hexapeptide

A synthetic hexapeptide GH secretagogue that produces a large GH pulse. With twice-daily use for 16 weeks the GH response partly fades, recovering after a break. It also binds receptors in the heart, and single IV doses raised heart pumping function in small studies. Not FDA-approved.

Half-life

~70 minutes

Typical Dose

100–200 mcg per injection, 1–2x/day

120/200

Route

subcutaneous

Category

growth_hormone

Evidence Overview

Strength of evidence across clinical, expert, and experimental lanes.

How Hexarelin is dosed in practice

Usually taken by subcutaneous (SubQ) injection. Typical range: 100–200 mcg per injection, 1–2x/day. Half-life: ~70 minutes. Each card gives the dose, frequency and duration from one evidence lane: Clinical (human trials), Expert (practitioner protocols) or Experimental (early or animal data). These ranges describe what has been studied or used; they are not a prescription.

Work out the units to draw with the reconstitution calculator, how long a vial lasts with the vial duration calculator, and how levels fall between doses with the half-life calculator.

clinical50% confidence

Twice-daily SubQ hexarelin for 16 weeks partly blunted the GH response, which recovered 4 weeks after stopping, and did not change IGF-1, body composition or bone density. Single IV doses acutely raised heart ejection fraction in some patients; intranasal and oral forms were tested in children.

Dose1.5 mcg/kg SubQ twice daily (adults); intranasal and oral regimens in children
FrequencyTwice daily
DurationUp to 16 weeks (SubQ); up to 8 months (intranasal, children)
Sources
  • 16-week SubQ trial in adults (1998, 1999)
  • Intranasal and oral studies in children (1995, 1996)
  • IV cardiac study (2002)
expert65% confidence

Used in short pulses (2 weeks on / 2 weeks off) for maximum GH stimulation. The cardioprotective angle makes it uniquely valuable for patients with cardiac concerns. Some practitioners use it specifically for post-cardiac event recovery in peptide-friendly clinics. Must cycle strictly to avoid desensitization.

Dose100–200 mcg SC, 1–2x/day
Frequency1–2 times daily, strict 2-week cycles
Duration2 weeks on / 2 weeks off, repeat as needed
Sources
  • Cardiology-focused peptide practitioners
  • Anti-aging medicine — GH pulse optimization protocols
  • Sports medicine clinics — short-cycle GH protocols
experimental60% confidence

Community knows hexarelin as the strongest but shortest-acting GHRP. Users report intense GH flush and hunger within minutes. Tachyphylaxis is well-documented — most users limit to 2-week bursts. Some use it specifically for the cardiac benefits rather than GH optimization.

Dose100–200 mcg per injection
Frequency1–2 times daily
Duration2 weeks max, then switch to ipamorelin or GHRP-2
Sources
  • Reddit r/Peptides — hexarelin cycling protocols
  • Bodybuilding forums — GH peptide rotation strategies
  • Cardiac health biohacking community protocols

Unlock Full Evidence Sources

Get complete clinical data, expert protocols, and experimental research for Hexarelin and 90+ other compounds with Pro.

Upgrade to Pro

Safety & Contraindications

  • Active cancer (strongest GH stimulus of all GHRPs)
  • Hyperprolactinemia (significant prolactin elevation at higher doses)
  • Cushing's syndrome or adrenal insufficiency (elevates cortisol)

Hexarelin: common questions

What is Hexarelin?

A synthetic hexapeptide GH secretagogue that produces a large GH pulse. With twice-daily use for 16 weeks the GH response partly fades, recovering after a break. It also binds receptors in the heart, and single IV doses raised heart pumping function in small studies. Not FDA-approved.

How is Hexarelin dosed?

Hexarelin is usually taken by subcutaneous (SubQ) injection. Typical range in DoseCraft's library: 100–200 mcg per injection, 1–2x/day. Clinical (human trials): 1.5 mcg/kg SubQ twice daily (adults); intranasal and oral regimens in children; Twice daily; Up to 16 weeks (SubQ); up to 8 months (intranasal, children). Expert (practitioner protocols): 100–200 mcg SC, 1–2x/day; 1–2 times daily, strict 2-week cycles; 2 weeks on / 2 weeks off, repeat as needed. Experimental (early or animal data): 100–200 mcg per injection; 1–2 times daily; 2 weeks max, then switch to ipamorelin or GHRP-2. These ranges describe what has been studied or used; they are not a prescription.

Is Hexarelin FDA-approved?

No. Hexarelin is not approved by the FDA for any use in people.

What is the half-life of Hexarelin?

DoseCraft's library lists a half-life of ~70 minutes. Half-life sets how often a compound is dosed and how long it takes to clear: about five half-lives.

Who should not use Hexarelin?

Listed contraindications: Active cancer (strongest GH stimulus of all GHRPs); Hyperprolactinemia (significant prolactin elevation at higher doses); Cushing's syndrome or adrenal insufficiency (elevates cortisol).

Information is for educational purposes only. Always consult a licensed healthcare provider before starting any peptide regimen.

Page updated . How we grade evidence: methodology.

Disclaimer: DoseCraft is for educational purposes only and does not provide medical advice. These compounds are not FDA-approved for the uses described. Always consult a qualified healthcare provider. Full disclaimer

Pro unlocks unlimited Coach + safety alerts.

Upgrade→